Sienna Biopharmaceuticals, Inc. Research and Development Expense
Sienna Biopharmaceuticals, Inc. reported Research and Development Expense of $3.82 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2019-11-12
- Sienna Biopharmaceuticals, Inc. research and development expense for the quarter ending 2019-09-30 was $3.82M, a 68.55% decline year-over-year.
- Sienna Biopharmaceuticals, Inc. research and development expense for the quarter ending 2019-06-30 was $5.08M, a 67.60% decline year-over-year.
- Sienna Biopharmaceuticals, Inc. research and development expense for the quarter ending 2019-03-31 was $7.09M, a 45.35% decline year-over-year.
- Sienna Biopharmaceuticals, Inc. research and development expense for the quarter ending 2018-12-31 was $10.77M, a 13.83% increase year-over-year.
- Sienna Biopharmaceuticals, Inc. research and development expense for fiscal 2018 was $51.59M, a 69.24% increase from fiscal 2017.
- Sienna Biopharmaceuticals, Inc. research and development expense for fiscal 2017 was $30.48M, a 177.30% increase from fiscal 2016.
- Sienna Biopharmaceuticals, Inc. research and development expense for fiscal 2016 was $10.99M, a 356.71% increase from fiscal 2015.
- Sienna Biopharmaceuticals, Inc. research and development expense for fiscal 2015 was $2.41M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2019-09-30 | $3.82M 10-Q · filed 2019-11-12 | $8.90M derived: sum of 2 quarters · filed 2019-11-12 | $16.00M 10-Q · filed 2019-11-12 | $26.77M derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-06-30 | $5.08M 10-Q · filed 2019-08-08 | $12.18M 10-Q · filed 2019-08-08 | $22.95M derived: sum of 3 quarters · filed 2019-08-08 | $35.10M derived: sum of 4 quarters · filed 2019-08-08 |
| 2019-03-31 | $7.09M 10-Q · filed 2019-05-08 | $17.87M derived: sum of 2 quarters · filed 2019-05-08 | $30.01M derived: sum of 3 quarters · filed 2019-05-08 | $45.70M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-12-31 | $10.77M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $22.92M derived: sum of 2 quarters · filed 2019-03-14 | $38.61M derived: sum of 3 quarters · filed 2019-08-08 | $51.59M 10-K · filed 2019-03-14 |
| 2018-09-30 | $12.15M 10-Q · filed 2019-11-12 | $27.84M derived: sum of 2 quarters · filed 2019-08-08 | $40.82M 10-Q · filed 2019-11-12 | $50.28M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-06-30 | $15.69M 10-Q · filed 2019-08-08 | $28.67M 10-Q · filed 2019-08-08 | $38.14M derived: sum of 3 quarters · filed 2019-08-08 | $47.53M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $12.98M 10-Q · filed 2019-05-08 | $22.44M derived: sum of 2 quarters · filed 2019-05-08 | $31.84M derived: sum of 3 quarters · filed 2019-05-08 | $38.55M derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $9.46M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $18.86M derived: sum of 2 quarters · filed 2019-03-14 | $25.57M derived: sum of 3 quarters · filed 2019-03-14 | $30.48M 10-K · filed 2019-03-14 |
| 2017-09-30 | $9.40M 10-Q · filed 2018-11-08 | $16.10M derived: sum of 2 quarters · filed 2018-11-08 | $21.02M 10-Q · filed 2018-11-08 | $24.85M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-06-30 | $6.70M 10-Q · filed 2018-08-09 | $11.62M 10-Q · filed 2018-08-09 | $15.45M derived: sum of 3 quarters · filed 2019-03-14 | $18.20M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-03-31 | $4.92M 10-Q · filed 2018-05-14 | $8.74M derived: sum of 2 quarters · filed 2019-03-14 | $11.49M derived: sum of 3 quarters · filed 2019-03-14 | $13.97M derived: sum of 4 quarters · filed 2019-03-14 |
| 2016-12-31 | $3.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $6.57M derived: sum of 2 quarters · filed 2019-03-14 | $9.06M derived: sum of 3 quarters · filed 2019-03-14 | $10.99M 10-K · filed 2019-03-14 |
| 2016-09-30 | $2.75M 10-Q · filed 2017-11-09 | $5.23M derived: sum of 2 quarters · filed 2017-11-09 | $7.17M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $2.48M 10-Q · filed 2017-09-07 | $4.42M 10-Q · filed 2017-09-07 | ||
| 2015-12-31 | $2.41M 10-K · filed 2018-03-15 |